Viewing Study NCT00755118


Ignite Creation Date: 2025-12-25 @ 4:42 AM
Ignite Modification Date: 2025-12-26 @ 3:43 AM
Study NCT ID: NCT00755118
Status: TERMINATED
Last Update Posted: 2015-10-07
First Post: 2008-09-17
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Lohp, 5-Fu/Lv and Bevacizumab, Alternative With Cpt-11, 5-Fu/Lv and Cetuximab In Metastatic Crc
Sponsor: University Hospital of Crete
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module